Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
出版年份 2020 全文链接
标题
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-03-11
DOI
10.1038/s41598-020-61510-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
- (2019) Jacopo Baglieri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis
- (2019) Aveline Filliol et al. SEMINARS IN LIVER DISEASE
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
- (2019) Aroosha Raja et al. Cells
- Future applications of FGF/FGFR inhibitors in cancer
- (2018) Gaia Cristina Ghedini et al. Expert Review of Anticancer Therapy
- Infigratinib mediates vascular normalization, impairs metastasis and improves chemotherapy in hepatocellular carcinoma
- (2018) Hung Huynh et al. HEPATOLOGY
- Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects
- (2018) Xiaoyun Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regorafenib reverses HGF-induced sorafenib resistance by inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma
- (2018) Weibo Chen et al. FEBS Open Bio
- Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
- (2017) Alexander Gerbes et al. GUT
- Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
- (2017) Peter Dietrich et al. GUT
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option
- (2017) Peter Dietrich et al. Oncotarget
- Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
- (2017) Yuki Haga et al. PLoS One
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence
- (2016) Wei Chen et al. Scientific Reports
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells
- (2015) Chao Sun et al. BMC CANCER
- Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?
- (2015) Jakob Paur et al. HEPATOLOGY
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening
- (2014) Thuy V. Nguyen et al. BIOMATERIALS
- Tg(Grm1) transgenic mice: A murine model that mimics spontaneous uveal melanoma in humans?
- (2014) Susanne Schiffner et al. EXPERIMENTAL EYE RESEARCH
- MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
- (2013) Hao Yang et al. HEPATOLOGY
- Fibroblast growth factor signaling in liver carcinogenesis
- (2013) Dalbir S. Sandhu et al. HEPATOLOGY
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
- (2012) S Hagiwara et al. BRITISH JOURNAL OF CANCER
- The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma
- (2010) Norifumi Harimoto et al. ONCOLOGY
- Mitogen-activated protein kinases in hepatocellular carcinoma development
- (2010) Lihua Min et al. SEMINARS IN CANCER BIOLOGY
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
- (2009) Hella Wobser et al. CELL RESEARCH
- FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis
- (2008) D J Mulder et al. GUT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now